Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy

Ads

You May Also Like

Moleculin Biotech, Inc. Reports Financial Results for the First Quarter Ended March 31, 2018

HOUSTON, May 15, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the ...

Merus Announces Second Quarter 2017 Financial Results and Highlights Recent Progress

UTRECHT, The Netherlands, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology ...